查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1280700

疫苗受託製造市场:2023年～2033年

Vaccine Contract Manufacturing Market Report 2023-2033
出版日期: | 出版商: Visiongain | 英文 375 Pages | 商品交期: 最快1-2个工作天内

价格

全球疫苗受託製造的市场规模，2022年是27亿5,030万美金。该市场，预计在预测期间的2023年～2033年以13.2％的年复合成长率扩大。

本报告提供全球疫苗受託製造市场相关调查，市场概要，以及各流程，各下游流程，各上游流程，各最终用途，各疫苗类型，各运用，各企业规模，各地区的趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 报告概要

第2章 摘要整理

第3章 市场概要

  • 主要调查结果
  • 市场动态
  • COVID-19影响分析
  • 波特的五力分析
  • PEST分析

第4章 疫苗受託製造市场分析，各流程

  • 主要调查结果
  • 适应市场区隔:市场魅力指数
  • 疫苗受託製造市场规模的估计与预测，各流程
  • 上游流程
  • 下游流程

第5章 疫苗受託製造市场分析，各下游流程

  • 主要调查结果
  • 下游流程市场区隔:市场魅力指数
  • 疫苗受託製造市场规模的估计与预测，各下游流程
  • 填充及最后製剂化
  • 分析及QC研究
  • 疫苗包装

第6章 疫苗受託製造市场分析，各上游流程

  • 主要调查结果
  • 上游流程市场区隔:市场魅力指数
  • 疫苗受託製造市场规模的估计与预测，各上游流程
  • 哺乳类表现疫苗类型
  • 细菌表现疫苗类型
  • 酵母表现疫苗类型
  • 桿状病毒/昆虫表现疫苗类型
  • 其他的上游流程

第7章 疫苗受託製造市场分析，各最终用途

  • 主要调查结果
  • 最终用途市场区隔:市场魅力指数
  • 疫苗受託製造市场规模的估计与预测，各最终用途
  • 对人的使用
  • 动物

第8章 疫苗受託製造市场分析，各疫苗类型

  • 主要调查结果
  • 疫苗类型市场区隔:市场魅力指数
  • 疫苗受託製造市场规模的估计与预测，各疫苗类型
  • 次单元疫苗
  • 弱毒化活病毒疫苗
  • 结合型疫苗
  • 不活化疫苗
  • 类毒素疫苗
  • 病毒载体疫苗
  • 重组载体疫苗
  • 其他

第9章 疫苗受託製造市场分析，各运用

  • 主要调查结果
  • 运用市场区隔:市场魅力指数
  • 疫苗受託製造市场规模的估计与预测，各运用
  • 前临床
  • 临床
  • 商业

第10章 疫苗受託製造市场分析，各企业规模

  • 主要调查结果
  • 企业规模市场区隔:市场魅力指数
  • 疫苗受託製造市场规模的估计与预测，各企业规模
  • 小规模厂商
  • 中坚厂商
  • 大製造商
  • 超大製造商

第11章 疫苗受託製造市场分析，各地区

第12章 北美的疫苗受託製造市场分析

第13章 欧洲的疫苗受託製造市场分析

第14章 亚太地区的疫苗受託製造市场分析

第15章 南美的疫苗受託製造市场分析

第16章 中东、非洲的疫苗受託製造市场分析

第17章 企业简介

  • 竞争情形，2022年
  • 策略性预测
  • Catalent, Inc
  • Emergent BioSolutions
  • Ajinomoto Bio-Pharma
  • Lonza
  • Curia Global, Inc.
  • WuXi Biologics
  • Vibalogics
  • FUJIFILM Holdings Corporation
  • Recipharm AB
  • Richter-Helm BioLogics GmbH &Co. KG
  • Bavarian Nordic
  • Charles River Laboratories
  • ICON plc
  • Batavia Biosciences B.V.
  • IDT Biologika

第18章 结论与推荐事项

Product Code: PHA1252

The global Vaccine Contract Manufacturing market was valued at US$2,750.3 million in 2022 and is projected to grow at a CAGR of 13.2% during the forecast period 2023-2033.

"The Vaccine Contract Manufacturing Market Report 2023-2033:" This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Increasing Global Demand, Product Innovation and Cost Effectiveness Driving Market Growth

The global demand for vaccines has been rising due to various factors, including population growth, aging populations, and the emergence of infectious diseases. This increasing demand creates opportunities for contract manufacturers to support vaccine developers in meeting the production needs, especially during pandemics or widespread outbreaks. Advances in vaccine research and development have led to the discovery of new vaccines and improved formulations. Contract manufacturers play a crucial role in translating these innovations into commercial products. As vaccine developers focus on R&D activities, they often seek external partners to handle manufacturing operations, driving the demand for contract manufacturing services. Contract manufacturing can provide cost-effective solutions for vaccine production. Establishing and maintaining large-scale manufacturing facilities can be capital-intensive for vaccine developers, while contract manufacturers can leverage their existing infrastructure, equipment, and expertise to produce vaccines at a lower cost per unit. This cost advantage makes contract manufacturing an attractive option for vaccine developers.

Regulations, Intellectual Property and Capacity Challenges to Hamper Industry Growth

The vaccine manufacturing industry is highly regulated, and contract manufacturers need to comply with stringent regulatory requirements imposed by regulatory authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Adhering to these regulations can be complex and time-consuming, leading to delays in production and increased costs. Vaccines often involve patented technologies and proprietary manufacturing processes. Contract manufacturers may face limitations or restrictions in accessing or using these technologies due to intellectual property rights held by the vaccine developers. Negotiating licensing agreements and protecting intellectual property can be challenging and may restrict the participation of certain contract manufacturers in the market. The manufacturing capacity for vaccines is limited, and there is often high demand, particularly during pandemics or widespread outbreaks. Contract manufacturers may face challenges in scaling up production to meet the required volumes within tight timelines. Limited capacity can result in delays, supply shortages, and increased competition among contract manufacturers for available projects.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the vaccine contract manufacturing market evolving?
  • What is driving and restraining the vaccine contract manufacturing market?
  • How will each vaccine contract manufacturing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
  • How will the market shares for each vaccine contract manufacturing submarket develop from 2023 to 2033?
  • What will be the main driver for the overall market from 2023 to 2033?
  • Will leading vaccine contract manufacturing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the vaccine contract manufacturing projects for these leading companies?
  • How will the industry evolve during the period between 2023 and 2033? What are the implications of vaccine contract manufacturing projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the vaccine contract manufacturing market?
  • Where is the vaccine contract manufacturing market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the vaccine contract manufacturing market today, and over the next 10 years:

  • Our 375-page report provides 143 tables and 229 charts/graphs exclusively to you
  • The report highlights key lucrative areas in the industry so you can target them - NOW
  • It contains in-depth analysis of global, regional and national sales and growth
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the vaccine contract manufacturing market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares
  • You will find original analyses, with business outlooks and developments
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising vaccine contract manufacturing prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V", "L", "W" and "U" are discussed in this report.

Segments Covered in the Report:

Process

  • Upstream Process
  • Downstream Process

Downstream Process

  • Fill & Finish Operations
  • Analytical & QC Studies
  • Vaccine Packaging

Upstream Process

  • Mammalian Expression Vaccine Type
  • Bacterial Expression Vaccine Type
  • Yeast Expression Vaccine Type
  • Baculovirus/insect Expression Vaccine Type
  • Other Upstream Process

End-use

  • Human Use
  • Veterinary

Type

  • Subunit Vaccines
  • Live Attenuated Vaccines
  • Conjugate Vaccines
  • Inactivated Vaccines
  • Toxoid Vaccines
  • Viral Vector Vaccines
  • Recombinant Vector Vaccines
  • Other Vaccine Types

Operation

  • Preclinical
  • Clinical
  • Commercial

Company Size

  • Small Manufacturers
  • Mid-sized Manufacturers
  • Large Manufacturers
  • Very Large Manufacturers

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 21 leading national markets:

North America

  • U.S
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA

The report also includes profiles and for some of the leading companies in the Vaccine Contract Manufacturing Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth:

  • Ajinomoto Bio-Pharma
  • Batavia Biosciences B.V
  • Bavarian Nordic
  • Catalent Inc
  • Charles River Laboratories
  • Curia Global, Inc
  • Emergent BioSolutions
  • FUJIFILM Holdings Corporation
  • ICON plc
  • IDT Biologika
  • Lonza
  • Recipharm AB
  • Richter-Helm BioLogics GmbH & Co. KG
  • Vibalogics
  • WuXi Biologics

Overall world revenue for Vaccine Contract Manufacturing Market, 2023 to 2033 in terms of value the market will surpass US$3,095.0 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Vaccine Contract Manufacturing Market, 2023 to 2033 report help you?

In summary, our 370+ page report provides you with the following knowledge:

  • Revenue forecasts to 2033 for Vaccine Contract Manufacturing Market, 2023 to 2033, with forecasts for process, upstream, downstream, end-use, type, operation and company size each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2033 for five regional and 21 key national markets - See forecasts for the Vaccine Contract Manufacturing Market, 2023 to 2033 in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the U.S., Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 15 of the major companies involved in the Vaccine Contract Manufacturing Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the vaccine contract manufacturing market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Vaccine Contract Manufacturing Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report
  • 1.6 Who is This Report for?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Reports
  • 1.10 About

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
    • 3.2.1 Market Driving Factors
      • 3.2.1.1 Growth in infectious diseases
      • 3.2.1.2 Stakeholder cooperation maximises manufacturing capacity
    • 3.2.2 Market Restraining Factors
      • 3.2.2.1 Material and equipment shortages
      • 3.2.2.2 Manufacturing process complexity
    • 3.2.3 Market Opportunities
      • 3.2.3.1 New vaccine technologies
      • 3.2.3.2 Gene-based vaccines
  • 3.3 COVID-19 Impact Analysis
  • 3.4 Porter's Five Forces Analysis
    • 3.4.1 Bargaining Power of Suppliers
    • 3.4.2 Bargaining Power of Buyers
    • 3.4.3 Competitive Rivalry
    • 3.4.4 Threat from Substitutes
    • 3.4.5 Threat of New Entrants
  • 3.5 PEST Analysis

4 Vaccine Contract Manufacturing Market Analysis by Process

  • 4.1 Key Findings
  • 4.2 Indication Segment: Market Attractiveness Index
  • 4.3 Vaccine Contract Manufacturing Market Size Estimation and Forecast by Process
  • 4.4 Upstream Process
    • 4.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.4.2 Market Share by Region, 2023 & 2033 (%)
  • 4.5 Downstream Process
    • 4.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 4.5.2 Market Share by Region, 2023 & 2033 (%)

5 Vaccine Contract Manufacturing Market Analysis by Downstream Process

  • 5.1 Key Findings
  • 5.2 Downstream Process Segment: Market Attractiveness Index
  • 5.3 Vaccine Contract Manufacturing Market Size Estimation and Forecast by Downstream Process
  • 5.4 Fill & Finish Operations
    • 5.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.4.2 Market Share by Region, 2023 & 2033 (%)
  • 5.5 Analytical & QC Studies
    • 5.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.5.2 Market Share by Region, 2023 & 2033 (%)
  • 5.6 Vaccine Packaging
    • 5.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 5.6.2 Market Share by Region, 2023 & 2033 (%)

6 Vaccine Contract Manufacturing Market Analysis by Upstream Process

  • 6.1 Key Findings
  • 6.2 Upstream Process Segment: Market Attractiveness Index
  • 6.3 Vaccine Contract Manufacturing Market Size Estimation and Forecast by Upstream Process
  • 6.4 Mammalian Expression Vaccine Type
    • 6.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.4.2 Market Share by Region, 2023 & 2033 (%)
  • 6.5 Bacterial Expression Vaccine Type
    • 6.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.5.2 Market Share by Region, 2023 & 2033 (%)
  • 6.6 Yeast Expression Vaccine Type
    • 6.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.6.2 Market Share by Region, 2023 & 2033 (%)
  • 6.7 Baculovirus/insect Expression Vaccine Type
    • 6.7.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.7.2 Market Share by Region, 2023 & 2033 (%)
  • 6.8 Other Upstream Process
    • 6.8.1 Market Size by Region, 2023-2033 (US$ Million)
    • 6.8.2 Market Share by Region, 2023 & 2033 (%)

7 Vaccine Contract Manufacturing Market Analysis by End-use

  • 7.1 Key Findings
  • 7.2 End-use Segment: Market Attractiveness Index
  • 7.3 Vaccine Contract Manufacturing Market Size Estimation and Forecast by End-use
  • 7.4 Human Use
    • 7.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 7.4.2 Market Share by Region, 2023 & 2033 (%)
  • 7.5 Veterinary
    • 7.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 7.5.2 Market Share by Region, 2023 & 2033 (%)

8 Vaccine Contract Manufacturing Market Analysis by Vaccine Type

  • 8.1 Key Findings
  • 8.2 Vaccine Type Segment: Market Attractiveness Index
  • 8.3 Vaccine Contract Manufacturing Market Size Estimation and Forecast by Vaccine Type
  • 8.4 Subunit Vaccines
    • 8.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 8.4.2 Market Share by Region, 2023 & 2033 (%)
  • 8.5 Live Attenuated Vaccines
    • 8.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 8.5.2 Market Share by Region, 2023 & 2033 (%)
  • 8.6 Conjugate Vaccines
    • 8.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 8.6.2 Market Share by Region, 2023 & 2033 (%)
  • 8.7 Inactivated Vaccines
    • 8.7.1 Market Size by Region, 2023-2033 (US$ Million)
    • 8.7.2 Market Share by Region, 2023 & 2033 (%)
  • 8.8 Toxoid Vaccines
    • 8.8.1 Market Size by Region, 2023-2033 (US$ Million)
    • 8.8.2 Market Share by Region, 2023 & 2033 (%)
  • 8.9 Viral Vector Vaccines
    • 8.9.1 Market Size by Region, 2023-2033 (US$ Million)
    • 8.9.2 Market Share by Region, 2023 & 2033 (%)
  • 8.10 Recombinant Vector Vaccines
    • 8.10.1 Market Size by Region, 2023-2033 (US$ Million)
    • 8.10.2 Market Share by Region, 2023 & 2033 (%)
  • 8.11 Other Vaccine Types
    • 8.11.1 Market Size by Region, 2023-2033 (US$ Million)
    • 8.11.2 Market Share by Region, 2023 & 2033 (%)

9 Vaccine Contract Manufacturing Market Analysis by Operation

  • 9.1 Key Findings
  • 9.2 Operation Segment: Market Attractiveness Index
  • 9.3 Vaccine Contract Manufacturing Market Size Estimation and Forecast by Operation
  • 9.4 Preclinical
    • 9.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 9.4.2 Market Share by Region, 2023 & 2033 (%)
  • 9.5 Clinical
    • 9.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 9.5.2 Market Share by Region, 2023 & 2033 (%)
  • 9.6 Commercial
    • 9.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 9.6.2 Market Share by Region, 2023 & 2033 (%)

10 Vaccine Contract Manufacturing Market Analysis by Company Size

  • 10.1 Key Findings
  • 10.2 Company Size Segment: Market Attractiveness Index
  • 10.3 Vaccine Contract Manufacturing Market Size Estimation and Forecast by Company Size
  • 10.4 Small Manufacturers
    • 10.4.1 Market Size by Region, 2023-2033 (US$ Million)
    • 10.4.2 Market Share by Region, 2023 & 2033 (%)
  • 10.5 Mid-sized Manufacturers
    • 10.5.1 Market Size by Region, 2023-2033 (US$ Million)
    • 10.5.2 Market Share by Region, 2023 & 2033 (%)
  • 10.6 Large Manufacturers
    • 10.6.1 Market Size by Region, 2023-2033 (US$ Million)
    • 10.6.2 Market Share by Region, 2023 & 2033 (%)
  • 10.7 Very Large Manufacturers
    • 10.7.1 Market Size by Region, 2023-2033 (US$ Million)
    • 10.7.2 Market Share by Region, 2023 & 2033 (%)

11 Vaccine Contract Manufacturing Market Analysis by Region

  • 11.1 Key Findings
  • 11.2 Regional Market Size Estimation and Forecast

12 North America Vaccine Contract Manufacturing Market Analysis

  • 12.1 Key Findings
  • 12.2 North America Vaccine Contract Manufacturing Market Attractiveness Index
  • 12.3 North America Vaccine Contract Manufacturing Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 12.4 North America Vaccine Contract Manufacturing Market Size Estimation and Forecast by Country
  • 12.5 North America Vaccine Contract Manufacturing Market Size Estimation and Forecast by Process
  • 12.6 North America Vaccine Contract Manufacturing Market Size Estimation and Forecast by Downstream Process
  • 12.7 North America Vaccine Contract Manufacturing Market Size Estimation and Forecast by Upstream Process
  • 12.8 North America Vaccine Contract Manufacturing Market Size Estimation and Forecast by End-users
  • 12.9 North America Vaccine Contract Manufacturing Market Size Estimation and Forecast by Vaccine Type
  • 12.10 North America Vaccine Contract Manufacturing Market Size Estimation and Forecast by Operation
  • 12.11 North America Vaccine Contract Manufacturing Market Size Estimation and Forecast by Company Size
  • 12.12 U.S. Vaccine Contract Manufacturing Market Analysis
  • 12.13 Canada Vaccine Contract Manufacturing Market Analysis

13 Europe Vaccine Contract Manufacturing Market Analysis

  • 13.1 Key Findings
  • 13.2 Europe Vaccine Contract Manufacturing Market Attractiveness Index
  • 13.3 Europe Vaccine Contract Manufacturing Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 13.4 Europe Vaccine Contract Manufacturing Market Size Estimation and Forecast by Country
  • 13.5 Europe Vaccine Contract Manufacturing Market Size Estimation and Forecast by Process
  • 13.6 Europe Vaccine Contract Manufacturing Market Size Estimation and Forecast by Downstream Process
  • 13.7 Europe Vaccine Contract Manufacturing Market Size Estimation and Forecast by Upstream Process
  • 13.8 Europe Vaccine Contract Manufacturing Market Size Estimation and Forecast by End-users
  • 13.9 Europe Vaccine Contract Manufacturing Market Size Estimation and Forecast by Vaccine Type
  • 13.10 Europe Vaccine Contract Manufacturing Market Size Estimation and Forecast by Operation
  • 13.11 Europe Vaccine Contract Manufacturing Market Size Estimation and Forecast by Company Size
  • 13.12 Germany Vaccine Contract Manufacturing Market Analysis
  • 13.13 UK Vaccine Contract Manufacturing Market Analysis
  • 13.14 France Vaccine Contract Manufacturing Market Analysis
  • 13.15 Italy Vaccine Contract Manufacturing Market Analysis
  • 13.16 Spain Vaccine Contract Manufacturing Market Analysis
  • 13.17 Russia Vaccine Contract Manufacturing Market Analysis
  • 13.18 Rest of Europe Vaccine Contract Manufacturing Market Analysis

14 Asia Pacific Vaccine Contract Manufacturing Market Analysis

  • 14.1 Key Findings
  • 14.2 Asia Pacific Vaccine Contract Manufacturing Market Attractiveness Index
  • 14.3 Asia Pacific Vaccine Contract Manufacturing Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 14.4 Asia Pacific Vaccine Contract Manufacturing Market Size Estimation and Forecast by Country
  • 14.5 Asia Pacific Vaccine Contract Manufacturing Market Size Estimation and Forecast by Process
  • 14.6 Asia Pacific Vaccine Contract Manufacturing Market Size Estimation and Forecast by Downstream Process
  • 14.7 Asia Pacific Vaccine Contract Manufacturing Market Size Estimation and Forecast by Upstream Process
  • 14.8 Asia Pacific Vaccine Contract Manufacturing Market Size Estimation and Forecast by End-users
  • 14.9 Asia Pacific Vaccine Contract Manufacturing Market Size Estimation and Forecast by Vaccine Type
  • 14.10 Asia Pacific Vaccine Contract Manufacturing Market Size Estimation and Forecast by Operation
  • 14.11 Asia Pacific Vaccine Contract Manufacturing Market Size Estimation and Forecast by Company Size
  • 14.12 China Vaccine Contract Manufacturing Market Analysis
  • 14.13 India Vaccine Contract Manufacturing Market Analysis
  • 14.14 Japan Vaccine Contract Manufacturing Market Analysis
  • 14.15 South Korea Vaccine Contract Manufacturing Market Analysis
  • 14.16 Australia Vaccine Contract Manufacturing Market Analysis
  • 14.17 Rest of Asia-Pacific Vaccine Contract Manufacturing Market Analysis

15 Latin America Vaccine Contract Manufacturing Market Analysis

  • 15.1 Key Findings
  • 15.2 Latin America Vaccine Contract Manufacturing Market Attractiveness Index
  • 15.3 Latin America Vaccine Contract Manufacturing Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 15.4 Latin America Vaccine Contract Manufacturing Market Size Estimation and Forecast by Country
  • 15.5 Latin America Vaccine Contract Manufacturing Market Size Estimation and Forecast by Process
  • 15.6 Latin America Vaccine Contract Manufacturing Market Size Estimation and Forecast by Downstream Process
  • 15.7 Latin America Vaccine Contract Manufacturing Market Size Estimation and Forecast by Upstream Process
  • 15.8 Latin America Vaccine Contract Manufacturing Market Size Estimation and Forecast by End-users
  • 15.9 Latin America Vaccine Contract Manufacturing Market Size Estimation and Forecast by Vaccine Type
  • 15.10 Latin America Vaccine Contract Manufacturing Market Size Estimation and Forecast by Operation
  • 15.11 Latin America Vaccine Contract Manufacturing Market Size Estimation and Forecast by Company Size
  • 15.12 Brazil Vaccine Contract Manufacturing Market Analysis
  • 15.13 Mexico Vaccine Contract Manufacturing Market Analysis
  • 15.14 Rest of Latin America Vaccine Contract Manufacturing Market Analysis

16 Middle East & Africa Vaccine Contract Manufacturing Market Analysis

  • 16.1 Key Findings
  • 16.2 Middle East & Africa Vaccine Contract Manufacturing Market Attractiveness Index
  • 16.3 Middle East & Africa Vaccine Contract Manufacturing Market by Country, 2023, 2028 & 2033 (US$ Million)
  • 16.4 Middle East & Africa Vaccine Contract Manufacturing Market Size Estimation and Forecast by Country
  • 16.5 Middle East & Africa Vaccine Contract Manufacturing Market Size Estimation and Forecast by Process
  • 16.6 Middle East & Africa Vaccine Contract Manufacturing Market Size Estimation and Forecast by Downstream Process
  • 16.7 Middle East & Africa Vaccine Contract Manufacturing Market Size Estimation and Forecast by Upstream Process
  • 16.8 Middle East & Africa Vaccine Contract Manufacturing Market Size Estimation and Forecast by End-users
  • 16.9 Middle East & Africa Vaccine Contract Manufacturing Market Size Estimation and Forecast by Vaccine Type
  • 16.10 Middle East & Africa Vaccine Contract Manufacturing Market Size Estimation and Forecast by Operation
  • 16.11 Middle East & Africa Vaccine Contract Manufacturing Market Size Estimation and Forecast by Company Size
  • 16.12 GCC Vaccine Contract Manufacturing Market Analysis
  • 16.13 South Africa Vaccine Contract Manufacturing Market Analysis
  • 16.14 Rest of MEA Vaccine Contract Manufacturing Market Analysis

17 Company Profiles

  • 17.1 Competitive Landscape, 2022
  • 17.2 Strategic Outlook
  • 17.3 Catalent, Inc
    • 17.3.1 Company Snapshot
    • 17.3.2 Company Overview
    • 17.3.3 Financial Analysis
      • 17.3.3.1 Net Revenue, 2017-2022
      • 17.3.3.2 Regional Market Shares, 2022
    • 17.3.4 Service Benchmarking
    • 17.3.5 Strategic Outlook
  • 17.4 Emergent BioSolutions
    • 17.4.1 Company Snapshot
    • 17.4.2 Company Overview
    • 17.4.3 Financial Analysis
      • 17.4.3.1 Net Revenue, 2017-2022
      • 17.4.3.2 R&D, 2017-2022
      • 17.4.3.3 Regional Market Shares, 2022
    • 17.4.4 Service Benchmarking
    • 17.4.5 Strategic Outlook
  • 17.5 Ajinomoto Bio-Pharma
    • 17.5.1 Company Snapshot
    • 17.5.2 Company Overview
    • 17.5.3 Financial Analysis
      • 17.5.3.1 Net Revenue, 2017-2022
      • 17.5.3.2 Regional Market Shares, 2022
    • 17.5.4 Service Benchmarking
    • 17.5.5 Strategic Outlook
  • 17.6 Lonza
    • 17.6.1 Company Snapshot
    • 17.6.2 Company Overview
    • 17.6.3 Financial Analysis
      • 17.6.3.1 Net Revenue, 2017-2022
      • 17.6.3.2 R&D, 2017-2022
      • 17.6.3.3 Regional Market Shares, 2022
    • 17.6.4 Service Benchmarking
    • 17.6.5 Strategic Outlook
  • 17.7 Curia Global, Inc.
    • 17.7.1 Company Snapshot
    • 17.7.2 Company Overview
    • 17.7.3 Service Benchmarking
    • 17.7.4 Strategic Outlook
  • 17.8 WuXi Biologics
    • 17.8.1 Company Snapshot
    • 17.8.2 Company Overview
    • 17.8.3 Financial Analysis
      • 17.8.3.1 Net Revenue, 2017-2022
      • 17.8.3.2 R&D, 2017-2022
      • 17.8.3.3 Regional Market Shares, 2022
    • 17.8.4 Service Benchmarking
    • 17.8.5 Strategic Outlook
  • 17.9 Vibalogics
    • 17.9.1 Company Snapshot
    • 17.9.2 Company Overview
    • 17.9.3 Service Benchmarking
    • 17.9.4 Strategic Outlook
  • 17.10 FUJIFILM Holdings Corporation
    • 17.10.1 Company Snapshot
    • 17.10.2 Company Overview
    • 17.10.3 Financial Analysis
      • 17.10.3.1 Net Revenue, 2017-2022
      • 17.10.3.2 R&D, 2017-2022
      • 17.10.3.3 Regional Market Shares, 2022
    • 17.10.4 Service Benchmarking
  • 17.11 Recipharm AB
    • 17.11.1 Company Snapshot
    • 17.11.2 Company Overview
    • 17.11.3 Service Benchmarking
    • 17.11.4 Strategic Outlook
  • 17.12 Richter-Helm BioLogics GmbH & Co. KG
    • 17.12.1 Company Snapshot
    • 17.12.2 Company Overview
    • 17.12.3 Service Benchmarking
    • 17.12.4 Strategic Outlook
  • 17.13 Bavarian Nordic
    • 17.13.1 Company Snapshot
    • 17.13.2 Company Overview
    • 17.13.3 Financial Analysis
      • 17.13.3.1 Net Revenue, 2017-2022
      • 17.13.3.2 R&D, 2017-2022
    • 17.13.4 Service Benchmarking
  • 17.14 Charles River Laboratories
    • 17.14.1 Company Snapshot
    • 17.14.2 Company Overview
    • 17.14.3 Financial Analysis
      • 17.14.3.1 Net Revenue, 2017-2022
      • 17.14.3.2 Regional Market Shares, 2022
    • 17.14.4 Service Benchmarking
    • 17.14.5 Strategic Outlook
  • 17.15 ICON plc
    • 17.15.1 Company Snapshot
    • 17.15.2 Company Overview
    • 17.15.3 Financial Analysis
      • 17.15.3.1 Net Revenue, 2017-2022
      • 17.15.3.2 R&D, 2017-2022
      • 17.15.3.3 Regional Market Shares, 2022
    • 17.15.4 Service Benchmarking
    • 17.15.5 Strategic Outlook
  • 17.16 Batavia Biosciences B.V.
    • 17.16.1 Company Snapshot
    • 17.16.2 Company Overview
    • 17.16.3 Service Benchmarking
  • 17.17 IDT Biologika
    • 17.17.1 Company Snapshot
    • 17.17.2 Company Overview
    • 17.17.3 Service Benchmarking

18 Conclusion and Recommendations

  • 18.1 Concluding Remarks from
  • 18.2 Recommendations for Market Players

List of Tables

  • Table 1 Vaccine Contract Manufacturing Market Snapshot, 2023 & 2033 (US$ Million, CAGR %)
  • Table 2 Vaccine Contract Manufacturing Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "V" Shaped Recovery
  • Table 3 Vaccine Contract Manufacturing Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "U" Shaped Recovery
  • Table 4 Vaccine Contract Manufacturing Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "W" Shaped Recovery
  • Table 5 Vaccine Contract Manufacturing Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%): "L" Shaped Recovery
  • Table 6 Vaccine Contract Manufacturing Market Forecast by Process, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 7 Upstream Process Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 8 Downstream Process Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 9 Vaccine Contract Manufacturing Market Forecast by Downstream Process, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 10 Fill & Finish Operations Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 11 Analytical & QC Studies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 12 Vaccine Packaging Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 13 Vaccine Contract Manufacturing Market Forecast by Upstream Process, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 14 Mammalian Expression Vaccine Type Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 15 Bacterial Expression Vaccine Type Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 16 Yeast Expression Vaccine Type Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 17 Baculovirus/insect Expression Vaccine Type Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 18 Other Upstream Process Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 19 Vaccine Contract Manufacturing Market Forecast by End-use, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 20 Human Use Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 21 Veterinary Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 22 Vaccine Contract Manufacturing Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 23 Subunit Vaccines Type Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 24 Live Attenuated Vaccines Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 25 Conjugate Vaccines Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 26 Inactivated Vaccines Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 27 Toxoid Vaccines Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 28 Viral Vector Vaccines Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 29 Recombinant Vector Vaccines Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 30 Other Vaccine Types Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 31 Vaccine Contract Manufacturing Market Forecast by Operation, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 32 Preclinical Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 33 Clinical Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 34 Commercial Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 35 Vaccine Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 36 Small Manufacturers Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 37 Mid-sized Manufacturer Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 38 Large Manufacturers Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 39 Very Large Manufacturers Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 40 Vaccine Contract Manufacturing Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 41 North America Vaccine Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 42 North America Vaccine Contract Manufacturing Market Forecast by Process, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 43 North America Vaccine Contract Manufacturing Market Forecast by Downstream Process, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 44 North America Vaccine Contract Manufacturing Market Forecast by Upstream Process, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 45 North America Vaccine Contract Manufacturing Market Forecast by End-use, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 46 North America Vaccine Contract Manufacturing Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 47 North America Vaccine Contract Manufacturing Market Forecast by Operation, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 48 North America Vaccine Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 49 U.S. Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 50 Canada Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 51 Europe Vaccine Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 52 Europe Vaccine Contract Manufacturing Market Forecast by Process, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 53 Europe Vaccine Contract Manufacturing Market Forecast by Downstream Process, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 54 Europe Vaccine Contract Manufacturing Market Forecast by Upstream Process, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 55 Europe Vaccine Contract Manufacturing Market Forecast by End-use, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 56 Europe Vaccine Contract Manufacturing Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 57 Europe Vaccine Contract Manufacturing Market Forecast by Operation, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 58 Europe Vaccine Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 59 Germany Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 60 UK Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 61 France Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 62 Italy Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 63 Spain Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 64 Russia Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 65 Rest of Europe Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 66 Asia Pacific Vaccine Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 67 Asia Pacific Vaccine Contract Manufacturing Market Forecast by Process, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 68 Asia Pacific Vaccine Contract Manufacturing Market Forecast by Downstream Process, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 69 Asia Pacific Vaccine Contract Manufacturing Market Forecast by Upstream Process, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 70 Asia Pacific Vaccine Contract Manufacturing Market Forecast by End-use, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 71 Asia Pacific Vaccine Contract Manufacturing Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 72 Asia Pacific Vaccine Contract Manufacturing Market Forecast by Operation, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 73 Asia Pacific Vaccine Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 74 China Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 75 India Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 76 Japan Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 77 South Korea Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 78 Australia Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 79 Rest of Asia-Pacific Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 80 Latin America Vaccine Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 81 Latin America Vaccine Contract Manufacturing Market Forecast by Process, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 82 Latin America Vaccine Contract Manufacturing Market Forecast by Downstream Process, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 83 Latin America Vaccine Contract Manufacturing Market Forecast by Upstream Process, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 84 Latin America Vaccine Contract Manufacturing Market Forecast by End-use, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 85 Latin America Vaccine Contract Manufacturing Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 86 Latin America Vaccine Contract Manufacturing Market Forecast by Operation, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 87 Latin America Vaccine Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 88 Brazil Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 89 Mexico Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 90 Rest of Latin America Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 91 Middle East & Africa Vaccine Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 92 Middle East & Africa Vaccine Contract Manufacturing Market Forecast by Process, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 93 Middle East & Africa Vaccine Contract Manufacturing Market Forecast by Downstream Process, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 94 Middle East & Africa Vaccine Contract Manufacturing Market Forecast by Upstream Process, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 95 Middle East & Africa Vaccine Contract Manufacturing Market Forecast by End-use, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 96 Middle East & Africa Vaccine Contract Manufacturing Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 97 Middle East & Africa Vaccine Contract Manufacturing Market Forecast by Operation, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 98 Middle East & Africa Vaccine Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 99 GCC Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 100 South Africa Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 101 Rest of MEA Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
  • Table 102 Strategic Outlook
  • Table 103 Catalent, Inc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 104 Catalent, Inc: Service Benchmarking
  • Table 105 Catalent, Inc: Strategic Outlook
  • Table 106 Emergent BioSolutions: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 107 Emergent BioSolutions: Service Benchmarking
  • Table 108 Emergent BioSolutions: Strategic Outlook
  • Table 109 Ajinomoto Bio-Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 110 Ajinomoto Bio-Pharma: Service Benchmarking
  • Table 111 Ajinomoto Bio-Pharma: Strategic Outlook
  • Table 112 Lonza: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 113 Lonza: Service Benchmarking
  • Table 114 Lonza: Strategic Outlook
  • Table 115 Curia Global, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 116 Curia Global Inc.: Service Benchmarking
  • Table 117 Curia Global Inc.: Strategic Outlook
  • Table 118 WuXi Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 119 WuXi Biologics: Service Benchmarking
  • Table 120 WuXi Biologics: Strategic Outlook
  • Table 121 Vibalogics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 122 Vibalogics: Service Benchmarking
  • Table 123 Vibalogics: Strategic Outlook
  • Table 124 FUJIFILM Holdings Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 125 FUJIFILM Holdings Corporation: Service Benchmarking
  • Table 126 Recipharm AB: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 127 Recipharm AB: Service Benchmarking
  • Table 128 Recipharm AB: Strategic Outlook
  • Table 129 Richter-Helm BioLogics GmbH & Co. KG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 130 Richter-Helm BioLogics GmbH & Co. KG: Service Benchmarking
  • Table 131 Richter-Helm BioLogics GmbH & Co. KG: Strategic Outlook
  • Table 132 Bavarian Nordic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 133 Bavarian Nordic: Service Benchmarking
  • Table 134 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 135 Charles River Laboratories: Service Benchmarking
  • Table 136 Charles River Laboratories: Strategic Outlook
  • Table 137 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 138 ICON plc: Service Benchmarking
  • Table 139 ICON plc: Strategic Outlook
  • Table 140 Batavia Biosciences B.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 141 Batavia Biosciences B.V.: Service Benchmarking
  • Table 142 IDT Biologika: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 143 IDT Biologika: Service Benchmarking
  •  

List of Figures

  • Figure 1 Vaccine Contract Manufacturing Market Segmentation
  • Figure 2 Vaccine Contract Manufacturing Market by Process Type: Market Attractiveness Index
  • Figure 3 Vaccine Contract Manufacturing Market by Downstream: Market Attractiveness Index
  • Figure 4 Vaccine Contract Manufacturing Market by Downstream: Market Attractiveness Index
  • Figure 5 Vaccine Contract Manufacturing Market by End-use: Market Attractiveness Index
  • Figure 6 Vaccine Contract Manufacturing Market by Vaccine Type: Market Attractiveness Index
  • Figure 7 Vaccine Contract Manufacturing Market by Operation: Market Attractiveness Index
  • Figure 8 Vaccine Contract Manufacturing Market by Company Size: Market Attractiveness Index
  • Figure 9 Vaccine Contract Manufacturing Market Attractiveness Index by Region
  • Figure 10 Vaccine Contract Manufacturing Market: Market Dynamics
  • Figure 11 Vaccine Contract Manufacturing Market by Region, 2023-2033 (US$ Million, AGR %): "V" Shaped Recovery
  • Figure 12 Vaccine Contract Manufacturing Market by Region, 2023-2033 (US$ Million, AGR %): "U" Shaped Recovery
  • Figure 13 Vaccine Contract Manufacturing Market by Region, 2023-2033 (US$ Million, AGR %): "W" Shaped Recovery
  • Figure 14 Vaccine Contract Manufacturing Market by Region, 2023-2033 (US$ Million, AGR %): "L" Shaped Recovery
  • Figure 15 Vaccine Contract Manufacturing Market: Porter's Five Forces Analysis
  • Figure 16 Vaccine Contract Manufacturing Market: PEST Analysis
  • Figure 17 Vaccine Contract Manufacturing Market by Process: Market Attractiveness Index
  • Figure 18 Vaccine Contract Manufacturing Market Forecast by Process, 2023-2033 (US$ Million, AGR %)
  • Figure 19 Vaccine Contract Manufacturing Market Share Forecast by Process, 2023, 2028, 2033 (%)
  • Figure 20 Upstream Process Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 21 Upstream Process Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 22 Downstream Process Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 23 Downstream Process Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 24 Vaccine Contract Manufacturing Market by Downstream Process: Market Attractiveness Index
  • Figure 25 Vaccine Contract Manufacturing Market Forecast by Downstream Process, 2023-2033 (US$ Million, AGR %)
  • Figure 26 Vaccine Contract Manufacturing Market Share Forecast by Downstream Process, 2023, 2028, 2033 (%)
  • Figure 27 Fill & Finish Operations Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 28 Fill & Finish Operations Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 29 Analytical & QC Studies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 30 Analytical & QC Studies Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 31 Vaccine Packaging Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 32 Vaccine Packaging Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 33 Vaccine Contract Manufacturing Market by Upstream Process: Market Attractiveness Index
  • Figure 34 Vaccine Contract Manufacturing Market Forecast by Upstream Process, 2023-2033 (US$ Million, AGR %)
  • Figure 35 Vaccine Contract Manufacturing Market Share Forecast by Upstream Process, 2023, 2028, 2033 (%)
  • Figure 36 Mammalian Expression Vaccine Type Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 37 Mammalian Expression Vaccine Type Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 38 Bacterial Expression Vaccine Type Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 39 Bacterial Expression Vaccine Type Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 40 Yeast Expression Vaccine Type Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 41 Yeast Expression Vaccine Type Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 42 Baculovirus/insect Expression Vaccine Type Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 43 Baculovirus/insect Expression Vaccine Type Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 44 Other Upstream Process Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 45 Other Upstream Process Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 46 Vaccine Contract Manufacturing Market by End-use: Market Attractiveness Index
  • Figure 47 Vaccine Contract Manufacturing Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
  • Figure 48 Vaccine Contract Manufacturing Market Share Forecast by End-use, 2023, 2028, 2033 (%)
  • Figure 49 Human Use Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 50 Human Use Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 51 Veterinary Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 52 Veterinary Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 53 Vaccine Contract Manufacturing Market by Vaccine Type: Market Attractiveness Index
  • Figure 54 Vaccine Contract Manufacturing Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR %)
  • Figure 55 Vaccine Contract Manufacturing Market Share Forecast by Vaccine Type, 2023, 2028, 2033 (%)
  • Figure 56 Subunit Vaccines Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 57 Subunit Vaccines Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 58 Live Attenuated Vaccines Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 59 Live Attenuated Vaccines Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 60 Conjugate Vaccines Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 61 Conjugate Vaccines Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 62 Inactivated Vaccines Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 63 Inactivated Vaccines Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 64 Toxoid Vaccines Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 65 Toxoid Vaccines Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 66 Viral Vector Vaccines Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 67 Viral Vector Vaccines Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 68 Recombinant Vector Vaccines Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 69 Recombinant Vector Vaccines Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 70 Other Vaccine Types Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 71 Other Vaccine Types Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 72 Vaccine Contract Manufacturing Market by Operation: Market Attractiveness Index
  • Figure 73 Vaccine Contract Manufacturing Market Forecast by Operation, 2023-2033 (US$ Million, AGR %)
  • Figure 74 Vaccine Contract Manufacturing Market Share Forecast by Operation, 2023, 2028, 2033 (%)
  • Figure 75 Preclinical Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 76 Preclinical Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 77 Clinical Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 78 Clinical Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 79 Commercial Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 80 Commercial Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 81 Vaccine Contract Manufacturing Market by Company Size: Market Attractiveness Index
  • Figure 82 Vaccine Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR %)
  • Figure 83 Vaccine Contract Manufacturing Market Share Forecast by Company Size, 2023, 2028, 2033 (%)
  • Figure 84 Small Manufacturers Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 85 Small Manufacturers Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 86 Mid-sized Manufacturers Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 87 Mid-sized Manufacturers Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 88 Large Manufacturers Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 89 Large Manufacturers Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 90 Very Large Manufacturers Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 91 Very Large Manufacturers Segment Market Share Forecast by Region, 2023 & 2033 (%)
  • Figure 92 Vaccine Contract Manufacturing Market Forecast by Region 2023 and 2033 (Revenue, CAGR%)
  • Figure 93 Vaccine Contract Manufacturing Market Share Forecast by Region 2023, 2028, 2033 (%)
  • Figure 94 Vaccine Contract Manufacturing Market by Region, 2023-2033 (US$ Million, AGR %)
  • Figure 95 North America Vaccine Contract Manufacturing Market Attractiveness Index
  • Figure 96 North America Vaccine Contract Manufacturing Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 97 North America Vaccine Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
  • Figure 98 North America Vaccine Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 99 North America Vaccine Contract Manufacturing Market Forecast by Process, 2023-2033 (US$ Million, AGR %)
  • Figure 100 North America Vaccine Contract Manufacturing Market Share Forecast by Process, 2023 & 2033 (%)
  • Figure 101 North America Vaccine Contract Manufacturing Market Forecast by Downstream Process, 2023-2033 (US$ Million, AGR %)
  • Figure 102 North America Vaccine Contract Manufacturing Market Share Forecast by Downstream Process, 2023 & 2033 (%)
  • Figure 103 North America Vaccine Contract Manufacturing Market Forecast by Upstream Process, 2023-2033 (US$ Million, AGR %)
  • Figure 104 North America Vaccine Contract Manufacturing Market Share Forecast by Upstream Process, 2023 & 2033 (%)
  • Figure 105 North America Vaccine Contract Manufacturing Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
  • Figure 106 North America Vaccine Contract Manufacturing Market Share Forecast by End-use, 2023 & 2033 (%)
  • Figure 107 North America Vaccine Contract Manufacturing Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR %)
  • Figure 108 North America Vaccine Contract Manufacturing Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
  • Figure 109 North America Vaccine Contract Manufacturing Market Forecast by Operation, 2023-2033 (US$ Million, AGR %)
  • Figure 110 North America Vaccine Contract Manufacturing Market Share Forecast by Operation, 2023 & 2033 (%)
  • Figure 111 North America Vaccine Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR %)
  • Figure 112 North America Vaccine Contract Manufacturing Market Share Forecast by Company Size, 2023 & 2033 (%)
  • Figure 113 U.S. Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 114 Canada Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 115 Europe Vaccine Contract Manufacturing Market Attractiveness Index
  • Figure 116 Europe Vaccine Contract Manufacturing Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 117 Europe Vaccine Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
  • Figure 118 Europe Vaccine Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 119 Europe Vaccine Contract Manufacturing Market Forecast by Process, 2023-2033 (US$ Million, AGR %)
  • Figure 120 Europe Vaccine Contract Manufacturing Market Share Forecast by Process, 2023 & 2033 (%)
  • Figure 121 Europe Vaccine Contract Manufacturing Market Forecast by Downstream Process, 2023-2033 (US$ Million, AGR %)
  • Figure 122 Europe Vaccine Contract Manufacturing Market Share Forecast by Downstream Process, 2023 & 2033 (%)
  • Figure 123 Europe Vaccine Contract Manufacturing Market Forecast by Upstream Process, 2023-2033 (US$ Million, AGR %)
  • Figure 124 Europe Vaccine Contract Manufacturing Market Share Forecast by Upstream Process, 2023 & 2033 (%)
  • Figure 125 Europe Vaccine Contract Manufacturing Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
  • Figure 126 Europe Vaccine Contract Manufacturing Market Share Forecast by End-use, 2023 & 2033 (%)
  • Figure 127 Europe Vaccine Contract Manufacturing Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR %)
  • Figure 128 Europe Vaccine Contract Manufacturing Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
  • Figure 129 Europe Vaccine Contract Manufacturing Market Forecast by Operation, 2023-2033 (US$ Million, AGR %)
  • Figure 130 Europe Vaccine Contract Manufacturing Market Share Forecast by Operation, 2023 & 2033 (%)
  • Figure 131 Europe Vaccine Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR %)
  • Figure 132 Europe Vaccine Contract Manufacturing Market Share Forecast by Company Size, 2023 & 2033 (%)
  • Figure 133 Germany Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 134 UK Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 135 France Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 136 Italy Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 137 Spain Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 138 Russia Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 139 Rest of Europe Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 140 Asia Pacific Vaccine Contract Manufacturing Market Attractiveness Index
  • Figure 141 Asia Pacific Vaccine Contract Manufacturing Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 142 Asia Pacific Vaccine Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
  • Figure 143 Asia Pacific Vaccine Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 144 Asia Pacific Vaccine Contract Manufacturing Market Forecast by Process, 2023-2033 (US$ Million, AGR %)
  • Figure 145 Asia Pacific Vaccine Contract Manufacturing Market Share Forecast by Process, 2023 & 2033 (%)
  • Figure 146 Asia Pacific Vaccine Contract Manufacturing Market Forecast by Downstream Process, 2023-2033 (US$ Million, AGR %)
  • Figure 147 Asia Pacific Vaccine Contract Manufacturing Market Share Forecast by Downstream Process, 2023 & 2033 (%)
  • Figure 148 Asia Pacific Vaccine Contract Manufacturing Market Forecast by Upstream Process, 2023-2033 (US$ Million, AGR %)
  • Figure 149 Asia Pacific Vaccine Contract Manufacturing Market Share Forecast by Upstream Process, 2023 & 2033 (%)
  • Figure 150 Asia Pacific Vaccine Contract Manufacturing Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
  • Figure 151 Asia Pacific Vaccine Contract Manufacturing Market Share Forecast by End-use, 2023 & 2033 (%)
  • Figure 152 Asia Pacific Vaccine Contract Manufacturing Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR %)
  • Figure 153 Asia Pacific Vaccine Contract Manufacturing Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
  • Figure 154 Asia Pacific Vaccine Contract Manufacturing Market Forecast by Operation, 2023-2033 (US$ Million, AGR %)
  • Figure 155 Asia Pacific Vaccine Contract Manufacturing Market Share Forecast by Operation, 2023 & 2033 (%)
  • Figure 156 Asia Pacific Vaccine Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$ Million, AGR %)
  • Figure 157 Asia Pacific Vaccine Contract Manufacturing Market Share Forecast by Company Size, 2023 & 2033 (%)
  • Figure 158 China Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 159 India Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 160 Japan Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 161 South Korea Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 162 Australia Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 163 Rest of Asia-Pacific Vaccine Contract Manufacturing Market Forecast, 2023-2033 (US$ Million, AGR %)
  • Figure 164 Latin America Vaccine Contract Manufacturing Market Attractiveness Index
  • Figure 165 Latin America Vaccine Contract Manufacturing Market by Region, 2023, 2028 & 2033 (US$ Million)
  • Figure 166 Latin America Vaccine Contract Manufacturing Market Forecast by Country, 2023-2033 (US$ Million, AGR %)
  • Figure 167 Latin America Vaccine Contract Manufacturing Market Share Forecast by Country, 2023 & 2033 (%)
  • Figure 168 Latin America Vaccine Contract Manufacturing Market Forecast by Process, 2023-2033 (US$ Million, AGR %)
  • Figure 169 Latin America Vaccine Contract Manufacturing Market Share Forecast by Process, 2023 & 2033 (%)
  • Figure 170 Latin America Vaccine Contract Manufacturing Market Forecast by Downstream Process, 2023-2033 (US$ Million, AGR %)
  • Figure 171 Latin America Vaccine Contract Manufacturing Market Share Forecast by Downstream Process, 2023 & 2033 (%)
  • Figure 172 Latin America Vaccine Contract Manufacturing Market Forecast by Upstream Process, 2023-2033 (US$ Million, AGR %)
  • Figure 173 Latin America Vaccine Contract Manufacturing Market Share Forecast by Upstream Process, 2023 & 2033 (%)
  • Figure 174 Latin America Vaccine Contract Manufacturing Market Forecast by End-use, 2023-2033 (US$ Million, AGR %)
  • Figure 175 Latin America Vaccine Contract Manufacturing Market Share Forecast by End-use, 2023 & 2033 (%)
  • Figure 176 Latin America Vaccine Contract Manufacturing Market Forecast by Vaccine Type, 2023-2033 (US$ Million, AGR %)
  • Figure 177 Latin America Vaccine Contract Manufacturing Market Share Forecast by Vaccine Type, 2023 & 2033 (%)
  • Figure 178 Latin America Vaccine Contract Manufacturing Market Forecast by Operation, 2023-2033 (US$ Million, AGR %)
  • Figure 179 Latin America Vaccine Contract Manufacturing Market Share Forecast by Operation, 2023 & 2033 (%)
  • Figure 180 Latin America Vaccine Contract Manufacturing Market Forecast by Company Size, 2023-2033 (US$)